vs

Side-by-side financial comparison of Easterly Government Properties, Inc. (DEA) and RIGEL PHARMACEUTICALS INC (RIGL). Click either name above to swap in a different company.

Easterly Government Properties, Inc. is the larger business by last-quarter revenue ($91.5M vs $69.8M, roughly 1.3× RIGEL PHARMACEUTICALS INC). RIGEL PHARMACEUTICALS INC runs the higher net margin — 384.0% vs 1.5%, a 382.5% gap on every dollar of revenue. On growth, RIGEL PHARMACEUTICALS INC posted the faster year-over-year revenue change (21.2% vs 16.4%). Over the past eight quarters, RIGEL PHARMACEUTICALS INC's revenue compounded faster (53.7% CAGR vs 9.6%).

Easterly Government Properties, Inc. is a U.S.-headquartered real estate investment trust focused on acquiring, developing, and managing mission-critical commercial properties primarily leased to U.S. federal government agencies. Its portfolio covers office spaces, healthcare facilities, and security-related properties, serving government clients across key domestic markets.

Rigel Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing targeted small molecule therapies for autoimmune, inflammatory, and hematologic diseases. Its approved flagship product treats adult immune thrombocytopenia, with primary operations and core markets in the United States, addressing unmet medical needs for underserved patient groups.

DEA vs RIGL — Head-to-Head

Bigger by revenue
DEA
DEA
1.3× larger
DEA
$91.5M
$69.8M
RIGL
Growing faster (revenue YoY)
RIGL
RIGL
+4.8% gap
RIGL
21.2%
16.4%
DEA
Higher net margin
RIGL
RIGL
382.5% more per $
RIGL
384.0%
1.5%
DEA
Faster 2-yr revenue CAGR
RIGL
RIGL
Annualised
RIGL
53.7%
9.6%
DEA

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DEA
DEA
RIGL
RIGL
Revenue
$91.5M
$69.8M
Net Profit
$1.4M
$268.1M
Gross Margin
91.5%
Operating Margin
33.2%
Net Margin
1.5%
384.0%
Revenue YoY
16.4%
21.2%
Net Profit YoY
-56.9%
1769.2%
EPS (diluted)
$0.36
$14.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DEA
DEA
RIGL
RIGL
Q1 26
$91.5M
Q4 25
$87.0M
$69.8M
Q3 25
$86.2M
$69.5M
Q2 25
$84.2M
$101.7M
Q1 25
$78.7M
$53.3M
Q4 24
$78.3M
$57.6M
Q3 24
$74.8M
$55.3M
Q2 24
$76.2M
$36.8M
Net Profit
DEA
DEA
RIGL
RIGL
Q1 26
$1.4M
Q4 25
$4.6M
$268.1M
Q3 25
$1.2M
$27.9M
Q2 25
$4.1M
$59.6M
Q1 25
$3.1M
$11.4M
Q4 24
$5.5M
$14.3M
Q3 24
$4.9M
$12.4M
Q2 24
$4.6M
$-1.0M
Gross Margin
DEA
DEA
RIGL
RIGL
Q1 26
Q4 25
77.3%
91.5%
Q3 25
76.0%
93.2%
Q2 25
77.2%
95.6%
Q1 25
77.4%
91.7%
Q4 24
76.1%
89.9%
Q3 24
77.7%
85.5%
Q2 24
76.2%
92.4%
Operating Margin
DEA
DEA
RIGL
RIGL
Q1 26
Q4 25
33.2%
Q3 25
40.9%
Q2 25
60.1%
Q1 25
23.9%
Q4 24
28.9%
Q3 24
25.4%
Q2 24
1.2%
Net Margin
DEA
DEA
RIGL
RIGL
Q1 26
1.5%
Q4 25
5.3%
384.0%
Q3 25
1.4%
40.2%
Q2 25
4.8%
58.6%
Q1 25
4.0%
21.5%
Q4 24
7.0%
24.9%
Q3 24
6.5%
22.5%
Q2 24
6.0%
-2.8%
EPS (diluted)
DEA
DEA
RIGL
RIGL
Q1 26
$0.36
Q4 25
$0.09
$14.11
Q3 25
$0.02
$1.46
Q2 25
$0.09
$3.28
Q1 25
$0.07
$0.63
Q4 24
$0.13
$0.82
Q3 24
$0.11
$0.70
Q2 24
$0.11
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DEA
DEA
RIGL
RIGL
Cash + ST InvestmentsLiquidity on hand
$2.0M
$155.0M
Total DebtLower is stronger
$52.5M
Stockholders' EquityBook value
$1.3B
$391.5M
Total Assets
$3.4B
$513.6M
Debt / EquityLower = less leverage
0.13×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DEA
DEA
RIGL
RIGL
Q1 26
$2.0M
Q4 25
$23.4M
$155.0M
Q3 25
$4.4M
$137.1M
Q2 25
$4.7M
$108.4M
Q1 25
$8.5M
$77.1M
Q4 24
$19.4M
$77.3M
Q3 24
$31.2M
$61.1M
Q2 24
$14.8M
$49.1M
Total Debt
DEA
DEA
RIGL
RIGL
Q1 26
Q4 25
$1.7B
$52.5M
Q3 25
$1.6B
$60.0M
Q2 25
$1.7B
$60.0M
Q1 25
$1.6B
$60.0M
Q4 24
$1.6B
$60.0M
Q3 24
$1.5B
$60.0M
Q2 24
$1.4B
$60.0M
Stockholders' Equity
DEA
DEA
RIGL
RIGL
Q1 26
$1.3B
Q4 25
$1.3B
$391.5M
Q3 25
$1.3B
$117.6M
Q2 25
$1.3B
$81.9M
Q1 25
$1.3B
$18.6M
Q4 24
$1.3B
$3.3M
Q3 24
$1.3B
$-14.6M
Q2 24
$1.3B
$-29.9M
Total Assets
DEA
DEA
RIGL
RIGL
Q1 26
$3.4B
Q4 25
$3.4B
$513.6M
Q3 25
$3.4B
$242.5M
Q2 25
$3.4B
$206.7M
Q1 25
$3.2B
$176.0M
Q4 24
$3.2B
$164.0M
Q3 24
$3.1B
$139.4M
Q2 24
$3.0B
$128.4M
Debt / Equity
DEA
DEA
RIGL
RIGL
Q1 26
Q4 25
1.26×
0.13×
Q3 25
1.23×
0.51×
Q2 25
1.29×
0.73×
Q1 25
1.20×
3.23×
Q4 24
1.21×
18.25×
Q3 24
1.12×
Q2 24
1.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DEA
DEA
RIGL
RIGL
Operating Cash FlowLast quarter
$22.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
0.08×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DEA
DEA
RIGL
RIGL
Q1 26
Q4 25
$259.2M
$22.0M
Q3 25
$155.0M
$24.0M
Q2 25
$38.1M
$30.5M
Q1 25
$24.2M
$-893.0K
Q4 24
$162.6M
$14.5M
Q3 24
$57.2M
$21.7M
Q2 24
$57.0M
$302.0K
Capex Intensity
DEA
DEA
RIGL
RIGL
Q1 26
0.7%
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Cash Conversion
DEA
DEA
RIGL
RIGL
Q1 26
Q4 25
56.44×
0.08×
Q3 25
127.75×
0.86×
Q2 25
9.36×
0.51×
Q1 25
7.73×
-0.08×
Q4 24
29.82×
1.01×
Q3 24
11.76×
1.75×
Q2 24
12.37×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DEA
DEA

Rental income$88.6M97%
Other$2.3M3%
Asset management income$646.0K1%

RIGL
RIGL

Segment breakdown not available.

Related Comparisons